The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01)
Phase 2
Completed
- Conditions
- COVID-19 Vaccines
- Interventions
- Biological: ARCT-154 Self-Amplifying RNA SARS-CoV-2 VaccineOther: Placebo (normal saline)Biological: Astra Zeneca COVID-19 vaccine
- First Posted Date
- 2021-08-19
- Last Posted Date
- 2023-10-16
- Lead Sponsor
- Vinbiocare Biotechnology Joint Stock Company
- Target Recruit Count
- 19494
- Registration Number
- NCT05012943
- Locations
- 🇻🇳
Pasteur Institute, Ho Chi Minh City, Ho Chi Minh, Vietnam
🇻🇳Military Medical University, Ha Noi, Vietnam
🇻🇳Hanoi Medical University, Ha Noi, Vietnam
© Copyright 2025. All Rights Reserved by MedPath